RVL Pharmaceuticals Q1 EPS $(0.12), Inline, Sales $8.83M Miss $9.44M Estimate

Benzinga · 05/11/2023 06:52
RVL Pharmaceuticals (NASDAQ:RVLP) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 50 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $8.83 million which missed the analyst consensus estimate of $9.44 million by 6.44 percent. This is a 58.81 percent decrease over sales of $21.44 million the same period last year.